Healthcare Sales & Marketing Network News: Virgan

Searching News Database: Virgan

HSMN NewsFeed - 3 Jun 2010
Bausch & Lomb Acquires Zirgan(R) (Ganciclovir Ophthalmic Gel 0.15%) From Sirion Therapeutics for the Treatment of Herpetic Keratitis
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 16 Sep 2009
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 26 Jan 2009
Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 16 Apr 2007
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 9 Apr 2007
Sirion Therapeutics Completes $45 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 17 Jan 2007
Sirion Therapeutics Acquires U.S. License to Develop New Treatment for Viral Eye Infection
Biopharmaceuticals Ophthalmology Licensing

Return to NewsFeed

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!